Rachel Archer

661 total citations
22 papers, 467 citations indexed

About

Rachel Archer is a scholar working on Rheumatology, Economics and Econometrics and Immunology. According to data from OpenAlex, Rachel Archer has authored 22 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 7 papers in Economics and Econometrics and 6 papers in Immunology. Recurrent topics in Rachel Archer's work include Rheumatoid Arthritis Research and Therapies (7 papers), Biosimilars and Bioanalytical Methods (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Rachel Archer is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Biosimilars and Bioanalytical Methods (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Rachel Archer collaborates with scholars based in United Kingdom, France and United States. Rachel Archer's co-authors include John Stevens, Matt Stevenson, M. Dawn Teare, Jonathan Tosh, Emma Everson-Hock, Emma Simpson, Suzy Paisley, Adam Young, Allan Wailoo and Mónica Hernández Alava and has published in prestigious journals such as SHILAP Revista de lepidopterología, Thorax and Health Technology Assessment.

In The Last Decade

Rachel Archer

20 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel Archer United Kingdom	11	131	120	92	87	86	22	467
Daniel G. Fernández‐Ávila Colombia	12	61 0.5×	203 1.7×	29 0.3×	90 1.0×	27 0.3×	146	566
Ahmad Naim United States	15	63 0.5×	194 1.6×	77 0.8×	96 1.1×	80 0.9×	45	781
Vernon F. Schabert United States	13	91 0.7×	201 1.7×	23 0.3×	132 1.5×	63 0.7×	30	461
Anjali Patwardhan United States	12	103 0.8×	64 0.5×	32 0.3×	51 0.6×	21 0.2×	29	389
Eleanor M. Pinto United Kingdom	9	61 0.5×	44 0.4×	85 0.9×	37 0.4×	171 2.0×	13	515
Paola Sabrina Buonuomo Italy	15	79 0.6×	71 0.6×	71 0.8×	44 0.5×	12 0.1×	65	564
Gorana Capkun Switzerland	12	123 0.9×	73 0.6×	16 0.2×	37 0.4×	33 0.4×	24	519
Neng Yu United States	19	125 1.0×	53 0.4×	95 1.0×	439 5.0×	32 0.4×	57	945
Johan Dalén United States	14	25 0.2×	117 1.0×	44 0.5×	121 1.4×	85 1.0×	29	534
Neerav Monga Canada	14	157 1.2×	48 0.4×	57 0.6×	17 0.2×	18 0.2×	28	718

Countries citing papers authored by Rachel Archer

Since Specialization

Citations

This map shows the geographic impact of Rachel Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Archer more than expected).

Fields of papers citing papers by Rachel Archer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Archer. The network helps show where Rachel Archer may publish in the future.

Co-authorship network of co-authors of Rachel Archer

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Archer. A scholar is included among the top collaborators of Rachel Archer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Archer. Rachel Archer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blackmore, Chris, et al.. (2020). Factors affecting the successful implementation of Global Polio Eradication Initiative (GPEI) in low- and middle-income countries. Journal of Global Health. 10(1). 10322–10322. 9 indexed citations

Essat, Munira, Rachel Archer, Nicolò Zarotti, et al.. (2019). Interventions to promote oral nutritional behaviours in people living with neurodegenerative disorders of the motor system: A systematic review. Clinical Nutrition. 39(8). 2547–2556. 10 indexed citations

Simpson, Emma, Shijie Ren, Emma Everson-Hock, et al.. (2019). Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis. International Journal of Technology Assessment in Health Care. 35(1). 36–44. 6 indexed citations

Blackmore, Chris, et al.. (2019). Factors influencing the implementation of Global Polio Eradication Initiative in low- and middle-income countries: a qualitative evidence synthesis. SHILAP Revista de lepidopterología. 3. 1 indexed citations

Archer, Rachel, Emma Everson-Hock, Jean Hamilton, et al.. (2018). Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews. Health Technology Assessment. 22(66). 1–294. 17 indexed citations

Stevenson, Matt, Allan Wailoo, Jonathan Tosh, et al.. (2017). The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate Methotrexate. The Journal of Rheumatology. 44(7). 973–980. 16 indexed citations

Bermejo, Iñigo, Matt Stevenson, Rachel Archer, et al.. (2017). Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 35(11). 1141–1151. 2 indexed citations

Paisley, Suzy, Jurica Ševa, Matt Stevenson, et al.. (2016). Identifying Potential Early Biomarkers Of Acute Myocardial Infarction In The Biomedical Literature: A Comparison Of Text Mining And Manual Sifting Techniques. Value in Health. 19(7). A367–A367. 1 indexed citations

Stevenson, Matt, Rachel Archer, Jonathan Tosh, et al.. (2016). Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. Health Technology Assessment. 20(35). 1–610. 116 indexed citations

10.

Tappenden, Paul, Shijie Ren, Rachel Archer, et al.. (2016). A Model-Based Economic Evaluation of Biologic and Non-Biologic Options for the Treatment of Adults with Moderately-to-Severely Active Ulcerative Colitis after the Failure of Conventional Therapy. PharmacoEconomics. 34(10). 1023–1038. 18 indexed citations

11.

Archer, Rachel, Paul Tappenden, Shijie Ren, et al.. (2016). Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technology Assessment. 20(39). 1–326. 54 indexed citations

12.

Archer, Rachel, Suzy Paisley, Munira Essat, Louise Preston, & Martin H. Thornhill. (2015). ITERATIVE SIFTING IN THE SELECTION OF RESEARCH EVIDENCE: IMPLICATIONS FOR REVIEWS AND OTHER DECISION PROBLEMS. International Journal of Technology Assessment in Health Care. 31(1-2). 54–58. 3 indexed citations

13.

Essat, Munira, Paul Tappenden, Shijie Ren, et al.. (2015). Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 34(3). 245–257. 15 indexed citations

14.

Teare, M. Dawn, et al.. (2015). Risk Prediction Models for Lung Cancer: A Systematic Review. Clinical Lung Cancer. 17(2). 95–106. 60 indexed citations

15.

Archer, Rachel, et al.. (2015). P278 Is there a role for telemedicine in cystic fibrosis? A systematic review. Thorax. 70(Suppl 3). A218.2–A219. 4 indexed citations

16.

Wailoo, Allan, Matt Stevenson, Jonathan Tosh, et al.. (2014). The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards. Value in Health. 17(7). A380–A380. 1 indexed citations

17.

Holmes, Michael, John Rathbone, Chris Littlewood, et al.. (2014). Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation. Health Technology Assessment. 18(16). 1–176. 32 indexed citations

18.

Tosh, Jonathan, Rachel Archer, Sarah Davis, Matt Stevenson, & John Stevens. (2013). Golimumab for the Treatment of Rheumatoid Arthritis After the Failure of Previous Disease-Modifying Antirheumatic Drugs: A NICE Single Technology Appraisal. PharmacoEconomics. 31(8). 653–661. 16 indexed citations

19.

Purshouse, Robin C., Alan Brennan, Rachid Rafia, et al.. (2012). Modelling the Cost-Effectiveness of Alcohol Screening and Brief Interventions in Primary Care in England. Alcohol and Alcoholism. 48(2). 180–188. 59 indexed citations

20.

Villiers, Charlotte, et al.. (2001). HAITI: AN EMERGENCY CALL TO REHABILITATE ITS ROAD INFRASTRUCTURE. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact